Wrocmedi Spółka z Ograniczoną Odpowiedzialnością (KRS 0000786135, NIP 7792505876) is a Polish company, headquartered in Poznań, Wielkopolskie voivodeship. Wrocmedi operates in: Other human health activities n.e.c. (PKD 86.90.E). Industry: Healthcare. The company has been listed in the National Court Register since May 14, 2019.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Wrocmedi
Identity
- Name
- Wrocmedi Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- May 14, 2019
- Registry status as of
- December 3, 2025
- Latest entry
- March 7, 2025
- Founding act
- 10.05.2019 R.
Articles of association history (2)
- May 10, 2019: 10.05.2019 R.
- January 30, 2020: 30.01.2020 R., ZMIANA § 5, § 6 UMOWY SPÓŁKI
Activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. JELENIOGÓRSKA, 16, 60-179, POZNAŃ, POLSKA
- Voivodeship
- WIELKOPOLSKIE
- District
- POZNAŃ
- WROCMEDI@GMAIL.COM
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 52.4079, 16.9335approx.
Risk and payment profile - Wrocmedi
Credibility rating
48.5 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
3
3/7 yrs
Board changes
1
1/7 yrs
PKD changes
0
0/7 yrs
Name changes
0
0/7 yrs
Data from 7 years of registry activity.
Credibility history
Payment reliability score from 2019–2022
Current: D (49/100)
Trend: deteriorating (-3.4 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Trade credit limit history
Standard limit from 2019–2022
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Wrocmedi
Founded
May 14, 2019
7 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
POZNAŃ
WIELKOPOLSKIE
Primary PKD
86.90.E
Other human health activities n.e.c.
Share capital
5.0 K PLN
100 shares total
Shareholders
1
shareholder
Board
1 person
Proxies: 1
Filed years
3 years
2019–2022
Registry entries
14
latest: March 7, 2025
Revenue
N/A
2022
Net profit
N/A
2022
Assets
0 PLN
2022
Equity
N/A
2022
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Wrocmedi.
No ratings
Related articles
News
Longevity Center launches Longevity Academy: Poland's first accredited longevity-medicine educational programme for doctors
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the world's first and Poland's first accredited longevity-medicine educational programme for doctors. Accreditation comes from the Polish Medical Chamber; the scientific partner is the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.
Explainer
Voxel in 2026: a Kraków operator of medical-imaging centres and radiopharmaceuticals, an mWIG40 issuer with a two-member management board
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of a medical-imaging centre network (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. Founded in 2005 and listed on the WSE since 2011, it operates under the Voxel-Diagnostic brand at several dozen locations across Poland. According to its 2025 financial statements, revenue reached PLN 583.8 million (up 15% year on year) with net profit of PLN 98.5 million. A two-member management board, a five-member supervisory board.
